Making viral vectors accessible for gene therapy patients requires that timelines are met with high quality AAV & LVV. Lucia Fernandez, VP of Manufacturing & Technology of VintaBio, will be speaking on Thursday March 28, 2024 at 1:45PM at the 7th Annual Gene Therapy for Rare Disorders Conference in Boston, MA. #GTxRD #Genetherapy #raredisease
VintaBio’s Post
More Relevant Posts
-
Head of Cell & Gene Therapy @ ICON plc |Collaboration Expert| Strategic Innovator| Change Agent| Entrepreneur
Calling all Cell & Gene Therapy supporters 📢 In one word, what do you say the Industry's top priority should be in 2024 in order to make these innovative therapies more accessible to those that can benefit from them most? Together we can accomplish more 🤝 #future #cellandgenetherapy #iconplc
To view or add a comment, sign in
-
Cell and gene therapy in the Asia-Pacific region https://lnkd.in/efNFUyFj learnings from local case studies. In this update, we share two case studies that explore how local innovators in the cell and gene therapy space in Asia-Pacific are addressing some of the major challenges for access in the region: that of overcoming complex manufacturing and delivery and improving affordability. https://lnkd.in/efNFUyFj #MarketAccess #HEOR #WeAreAvalereHealth
To view or add a comment, sign in
-
With the increasing demand for efficient AAV production in gene therapy, how will we face the current manufacturing challenges? Dovile Gruzdyte, Product Manager, discusses the impact of stable producer cell lines in revolutionizing mAb therapies and how we're gearing up to bring similar technology to AAV-based gene therapy. Read now: https://lnkd.in/e7CD5BXJ #genetherapy #celllinedevelopment #aavmanufacturing
To view or add a comment, sign in
-
With the Casgevy and Lyfgenia regulatory approvals breaking remarkable new ground in the treatment of sickle cell disease, SelectScience® is putting the spotlight on the opportunities and challenges in cell and gene therapy. Dive into this #AcceleratingScience feature #CGT #AAV #personalisedmedicine #genetherapies #cellandgenetherapy
Exciting news! Our highly anticipated Cell and Gene Therapy Accelerating Science feature is now live. Dive into the future of this field, exploring revolutionary breakthroughs and insights. #Celltherapy #Genetherapy #CGT #AcceleratingScience
Visit the special feature
selectscience.net
To view or add a comment, sign in
-
With the increasing demand for efficient AAV production in gene therapy, how will we face the current manufacturing challenges? Dovile Gruzdyte, Product Manager, discusses the impact of stable producer cell lines in revolutionizing mAb therapies and how we're gearing up to bring similar technology to AAV-based gene therapy. Read now: https://lnkd.in/e7CD5BXJ #genetherapy #celllinedevelopment #aavmanufacturing
To view or add a comment, sign in
-
Supporting the marketing strategies of scientific manufacturers by providing bespoke content led digital marketing programs to reach a targeted global audience of Scientists and Clinicians.
Exciting News in Cell and Gene Therapy! 🧬 Check out our insightful editorial feature on the latest advancements in the field, exploring some revolutionary breakthroughs!
Exciting news! Our highly anticipated Cell and Gene Therapy Accelerating Science feature is now live. Dive into the future of this field, exploring revolutionary breakthroughs and insights. #Celltherapy #Genetherapy #CGT #AcceleratingScience
Visit the special feature
selectscience.net
To view or add a comment, sign in
-
Looking ahead for cell and gene therapy DDW’s Megan Thomas discusses the future of the cell and gene therapy (CGT) sector with industry experts, who predict what to expect in 2024 and beyond. https://lnkd.in/eX-_e_rc #CGT #CellTherapy #GeneTherapy
To view or add a comment, sign in
-
Cell and gene therapy has often made headlines due to its nontraditional cost model, but the value of this transformative medicine is often overlooked. ARM's Gene Therapy for Patients and Society (GPS) framework, released at the Biotech Showcase during #JPM24, and CAR-T Therapy for Patients and Society (CAR-PS) framework, released last month, demonstrate how these advanced medicines are poised to provide incredible value. Unpack both value frameworks on our website here: https://lnkd.in/eX2TJiYf
To view or add a comment, sign in
-
With the increasing demand for efficient AAV production in gene therapy, how will we face the current manufacturing challenges? Dovile Gruzdyte, Product Manager, discusses the impact of stable producer cell lines in revolutionizing mAb therapies and how we're gearing up to bring similar technology to AAV-based gene therapy. Read now: https://lnkd.in/e7CD5BXJ #genetherapy #celllinedevelopment #aavmanufacturing
To view or add a comment, sign in
2,962 followers